Cargando…
Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more
Although cancer immunotherapy using immune checkpoint inhibitors (ICIs) has been recognized as one of the major treatment modalities for malignant diseases, the clinical outcome is not uniform in all cancer patients. Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous population of im...
Autores principales: | Shibata, Masahiko, Nanno, Kotaro, Yoshimori, Daigo, Nakajima, Takahiro, Takada, Makoto, Yazawa, Takashi, Mimura, Kousaku, Inoue, Norio, Watanabe, Takafumi, Tachibana, Kazunoshin, Muto, Satoshi, Momma, Tomoyuki, Suzuki, Yoshiyuki, Kono, Koji, Endo, Shungo, Takenoshita, Seiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671473/ https://www.ncbi.nlm.nih.gov/pubmed/36395389 http://dx.doi.org/10.18632/oncotarget.28303 |
Ejemplares similares
-
Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma
por: Aoto, Keita, et al.
Publicado: (2018) -
Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers
por: YAZAWA, TAKASHI, et al.
Publicado: (2013) -
Long-term Outcomes of Lower Rectal Cancer Patients Treated with Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection after Preoperative Radiotherapy or Chemoradiotherapy
por: Sakamoto, Wataru, et al.
Publicado: (2021) -
Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
por: Kono, Koji, et al.
Publicado: (2013) -
Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer
por: WATANABE, TAKAFUMI, et al.
Publicado: (2014)